A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors
2003 · British Journal of Cancer · 24 citations
https://doi.org/10.1038/sj.bjc.6600667
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
1.9K
Citations
25
h-index
41
i10-index
Mariko Shimamura is an academic researcher from The University of Osaka. The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Neuropeptides and Animal Physiology & Peptidase Inhibition and Analysis. The author has an h-index of 25, co-authored 58 publications.
Click to start Chat